S&P 500
(0.37%) 5 326.53 points
Dow Jones
(-0.29%) 39 557 points
Nasdaq
(0.85%) 16 944 points
Oil
(1.33%) $78.60
Gas
(1.86%) $2.90
Gold
(-1.09%) $2 366.70
Silver
(-1.45%) $31.04
Platinum
(0.04%) $1 050.10
USD/EUR
(-0.29%) $0.921
USD/NOK
(-0.82%) $10.61
USD/GBP
(-0.15%) $0.785
USD/RUB
(-0.85%) $89.43

Realtime updates for Smith & Nephew plc [SN.L]

Exchange: LSE Industry: Medical Devices
Last Updated23 May 2024 @ 09:28

-2.29% £ 991.80

Live Chart Being Loaded With Signals

Commentary (23 May 2024 @ 09:28):

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures...

Stats
Today's Volume 1.55M
Average Volume 3.67M
Market Cap 8.67B
EPS £0 ( 2024-05-01 )
Next earnings date ( £0 ) 2024-07-31
Last Dividend £18.38 ( 2023-03-30 )
Next Dividend £0 ( N/A )
P/E 41.33
ATR14 £0.745 (0.08%)

Volume Correlation

Long: 0.22 (neutral)
Short: 0.20 (neutral)
Signal:(55.609) Neutral

Smith & Nephew plc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Smith & Nephew plc Correlation - Currency/Commodity

The country flag 0.15
( neutral )
The country flag 0.16
( neutral )
The country flag -0.44
( neutral )
The country flag 0.35
( neutral )
The country flag 0.19
( neutral )
The country flag 0.45
( neutral )

Smith & Nephew plc Financials

Annual 2023
Revenue: £5.55B
Gross Profit: £3.82B (68.82 %)
EPS: £0.300
FY 2023
Revenue: £5.55B
Gross Profit: £3.82B (68.82 %)
EPS: £0.300
FY 2022
Revenue: £5.22B
Gross Profit: £3.68B (70.47 %)
EPS: £0.250
FY 2021
Revenue: £5.21B
Gross Profit: £3.67B (70.40 %)
EPS: £0.598

Financial Reports:

No articles found.

Smith & Nephew plc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
£12.91
(N/A)
£0
(N/A)
£18.38
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)

Smith & Nephew plc Dividend Information - Dividend Knight

Dividend Sustainability Score: 8.49 - good (84.92%) | Divividend Growth Potential Score: 6.46 - Stable (29.26%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend £3.45 1993-05-10
Last Dividend £18.38 2023-03-30
Next Dividend £0 N/A
Payout Date 2023-05-17
Next Payout Date N/A
# dividends 64 --
Total Paid Out £440.59 --
Avg. Dividend % Per Year 1.26% --
Score 4.39 --
Div. Sustainability Score 8.49
Div.Growth Potential Score 6.46
Div. Directional Score 7.48 --
Next Divdend (Est)
(2024-06-18)
£0 Estimate 1.28 %
Dividend Stability
0.10 Bad
Dividend Score
4.39
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield
1993 £0 0.00%
1994 £0 0.00%
1995 £0 0.00%
1996 £0 0.00%
1997 £0 0.00%
1998 £0 0.00%
1999 £0 0.00%
2000 £0 0.00%
2001 £0 0.00%
2002 £0 0.00%
2003 £0 0.00%
2004 £0 0.00%
2005 £0 0.00%
2006 £0 0.00%
2007 £0 0.00%
2008 £0 0.00%
2009 £0 0.00%
2010 £0 0.00%
2011 £0 0.00%
2012 £0 0.00%
2013 £0 0.00%
2014 £0 0.00%
2015 £0 0.00%
2016 £0 0.00%
2017 £0 0.00%
2018 £26.91 1.93%
2019 £28.49 1.99%
2020 £29.73 1.62%
2021 £27.12 1.73%
2022 £31.31 2.40%
2023 £18.38 1.64%
2024 £0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for LSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
VIC.L Dividend Knight 2023-06-08 Semi-Annually 2 0.88%
MINI.L No Dividend Player 2023-09-28 Annually 9 0.05%
CWK.L Dividend Knight 2023-07-20 Semi-Annually 32 1.30%
SGRO.L Dividend Knight 2023-08-10 Semi-Annually 32 1.77%
IBST.L Dividend Knight 2023-08-24 Annually 9 2.72%
BCPT.L Dividend Knight 2023-09-14 Monthly 20 2.80%
NTV.L Dividend Knight 2023-07-20 Semi-Annually 25 4.03%
EJFI.L Dividend Knight 2023-08-03 Quarterly 8 4.93%
SRP.L Dividend Knight 2023-09-07 Annually 32 0.97%
JCGI.L Dividend Knight 2023-07-20 Quarterly 31 2.30%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.04741.5009.0510.00[0 - 0.5]
returnOnAssetsTTM0.02631.2009.1210.00[0 - 0.3]
returnOnEquityTTM0.05031.500-0.552-0.828[0.1 - 1]
payoutRatioTTM1.243-1.00010.00-10.00[0 - 1]
currentRatioTTM1.7750.8006.134.90[1 - 3]
quickRatioTTM0.5690.800-1.359-1.087[0.8 - 2.5]
cashRatioTTM0.1331.500-0.372-0.558[0.2 - 2]
debtRatioTTM0.309-1.5004.85-7.28[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM0.6952.009.7710.00[0 - 30]
freeCashFlowPerShareTTM0.2072.009.9010.00[0 - 20]
debtEquityRatioTTM0.591-1.5007.64-10.00[0 - 2.5]
grossProfitMarginTTM0.7011.0001.6441.644[0.2 - 0.8]
operatingProfitMarginTTM0.1231.0009.549.54[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1971.000-0.0159-0.0159[0.2 - 2]
assetTurnoverTTM0.5560.8009.637.70[0.5 - 2]
Total Score8.49

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM43.001.0005.760[1 - 100]
returnOnEquityTTM0.05032.50-0.355-0.828[0.1 - 1.5]
freeCashFlowPerShareTTM0.2072.009.9310.00[0 - 30]
dividendYielPercentageTTM2.711.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM0.6952.009.7710.00[0 - 30]
payoutRatioTTM1.2431.50010.00-10.00[0 - 1]
pegRatioTTM1 420.391.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1101.0009.760[0.1 - 0.5]
Total Score6.46

Smith & Nephew plc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Smith & Nephew plc

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators